Is Gian Life Care a good stock to invest in?

Gian Life Care can be analyzed on the following key metrics - TTM P/E: 5.67 Sector P/E: 22.75 Dividend Yield: 0% D/E ratio: -

Gian Life Care Share Price

Sector: Healthcare Facilities

Powered by

16.45 -0.22 (-1.32%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 16.00

Today’s High 16.86

52 Week Low 12.06

52 Week High 26.98

Key Metrics

Market Cap (In Cr) 17.29
Beta 2.17
Div. Yield (%) 0
P/B 0.89
TTM P/E 5.67
Peg Ratio 0.16
Sector P/E 22.75
D/E 0
Open Price 16
Prev Close 16.67

View All Metrics

Gian Life Care Analysis

Price Analysis

1 Week

4.84%
3 Months

18.56%
6 Month

-11.99%
YTD

-11.33%
1 Year

-13.81%

Risk Meter

51% Low risk
51% Moderate risk
51% Balanced Risk
51% High risk
51% Extreme risk

Gian Life Care News

California-based tech giant Apple is reportedly set to enhance its iOS 18.2 update with a new battery intelligence feature that aims to provide users with real-time information on how long their iPhone will take to recharge.

Premium

New iOS 18.2 feature to show iPhone charging time estimations: Report

1 min read . 06 Nov 2024

Premium

Gian Life Care Q1 Results Live: Profit Falls by 64.9% YOY

1 min read . 16 Aug 2024

View More News

Gian Life Care Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
13.12

Selling/ General/ Admin Expenses Total
0.96

Depreciation/ Amortization
0.53

Other Operating Expenses Total
4.32

Total Operating Expense
7.58

Operating Income
5.54

Net Income Before Taxes
5.75

Net Income
4.15

Diluted Normalized EPS
4.02

Period
2023

Total Revenue
11.92

Selling/ General/ Admin Expenses Total
1.77

Depreciation/ Amortization
0.5

Other Operating Expenses Total
5.56

Total Operating Expense
10.6

Operating Income
1.33

Net Income Before Taxes
1.59

Net Income
1.06

Diluted Normalized EPS
1.03

Period
2022

Total Revenue
15.93

Selling/ General/ Admin Expenses Total
1.31

Depreciation/ Amortization
0.33

Other Operating Expenses Total
5.78

Total Operating Expense
10.23

Operating Income
5.7

Net Income Before Taxes
5.85

Net Income
4.37

Diluted Normalized EPS
4.23

Period
2021

Total Revenue
10.45

Selling/ General/ Admin Expenses Total
0.94

Depreciation/ Amortization
0.29

Other Operating Expenses Total
2.89

Total Operating Expense
7.69

Operating Income
2.77

Net Income Before Taxes
2.75

Net Income
2.02

Diluted Normalized EPS
1.95

Period
2020

Total Revenue
7.65

Selling/ General/ Admin Expenses Total
1.07

Depreciation/ Amortization
0.26

Other Operating Expenses Total
2.98

Total Operating Expense
5.89

Operating Income
1.76

Net Income Before Taxes
1.56

Net Income
1.13

Diluted Normalized EPS
1.42

Period
2019

Total Revenue
0.56

Selling/ General/ Admin Expenses Total
0.11

Depreciation/ Amortization
0.02

Other Operating Expenses Total
0.18

Total Operating Expense
0.38

Operating Income
0.17

Net Income Before Taxes
0.14

Net Income
0.1

Diluted Normalized EPS
0.1

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Gian Life Care Technical

Moving Average SMA

5 Day15.88
10 Day15.91
20 Day16.08

50 Day16.75
100 Day16.97
300 Day19.08

Gian Life Care Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Chennai Meenakshi Multi Hospital
32.08
-1
-3.02
59.9
28.34
23.96

Family Care Hospitals
4.6
-0.03
-0.65
9.5
3.4
24.74

Gian Life Care
16.45
-0.22
-1.32
26.98
12.06
17.29

Broach Lifecare Hospital
19.88
0
0
52.36
16.01
12.07

Dhanvantri Jeevan Rekha
16.95
-0.15
-0.88
25.2
16.47
6.95

Gian Life Care Shareholding

Shareholding Pattern

*Promoter pledging: 19.92%

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

14-Feb-25
Quarterly Results

14-Nov-24
Quarterly Results

23-Aug-24
Others

14-Aug-24
Quarterly Results

30-May-24
Audited Results

13-Jan-24
Quarterly Results

11-Nov-23
Quarterly Results

11-Aug-23
Quarterly Results

30-May-23
Audited Results

14-Nov-22
Half Yearly Results

Meeting Date
Announced on
Purpose

30-Sept-24
05-Sept-24
AGM

30-Sept-23
13-Sept-23
AGM

22-Mar-22
16-Feb-22
POM

16-Mar-21
03-Mar-21
AGM

Announced on
Record Date
Ex-Bonus
Description

14-Feb-22
30-Mar-22
29-Mar-22
Bonus issue of equity shares in the ratio of 6:5 of Rs. 10/-.

View All

Company Profile

ABOUT Gian Life Care

Industry Healthcare Facilities
ISIN INE063601012
BSE Code 542918

Gian Life Care Limited is an India-based pathology provider. The Company is engaged in the business of providing diagnostic and related healthcare tests and services in various cities connecting Kanpur and nearby areas. The Company offers a range of approximately 1,344 tests, which includes various tests ranging from biochemistry, clinical pathology, coagulation, cytogenetics, cytology and hematology, among others. It is mainly engaged in the business of pathological investigations. The Company provides a range of diagnostic and related healthcare tests and services, such as patient diagnosis, prevention and wellness diagnosis services to its patients and healthcare providers. The Company is focused on opening several diagnostics labs in various parts of the state. Its subsidiaries include Gian Path Lab (India) Pvt Ltd and Gian Satguru Pathology LLP. Its customers include individual patients, hospitals, other healthcare providers and corporate customers.

MANAGEMENT

Avani Gupta Chief Financial Officer
Vanshul Asnani Compliance Officer, Company Secretary
Arun Gupta Managing Director, Executive Director

GIAN LIFE CARE SUMMARY

Gian Life Care is trading 1.32% lower at Rs 16.45 as compared to its last closing price. Gian Life Care has been trading in the price range of 16.86 & 16.00. Gian Life Care has given -11.33% in this year & 4.84% in the last 5 days.

Gian Life Care has TTM P/E ratio 5.67 as compared to the sector P/E of 22.75.

The company posted a net profit of 0.12 Crores in its last quarter.

Listed peers of Gian Life Care include Chennai Meenakshi Multi Hospital (-3.02%), Family Care Hospitals (-0.65%), Gian Life Care (-1.32%) etc.

Gian Life Care has a 31.99% promoter holding & 68.01% public holding.

FAQs about Gian Life Care

Gian Life Care is trading at 16.45 as on 22 May, 2025 3:27:11 PM. This is -1.32% lower as compared to its previous closing price of 16.67

The market capitalization of Gian Life Care is 17.29 Cr as on 22 May, 2025 3:27:11 PM.

The 52 wk high for Gian Life Care is 26.98 whereas the 52 wk low is 12.06

Gian Life Care can be analyzed on the following key metrics -

TTM P/E: 5.67
Sector P/E: 22.75
Dividend Yield: 0%
D/E ratio: -

Gian Life Care reported a net profit of 4.15 Cr in 2024.

Gian Life Care Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Gian Life Care Share Price

Price Range

Key Metrics

Gian Life Care Analysis

Gian Life Care News

New iOS 18.2 feature to show iPhone charging time estimations: Report

Gian Life Care Q1 Results Live: Profit Falls by 64.9% YOY

Gian Life Care Financials

Forecast

Forecast

Forecast

Gian Life Care Technical

Gian Life Care Peers

Gian Life Care Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Gian Life Care

MANAGEMENT

GIAN LIFE CARE SUMMARY

FAQs about Gian Life Care

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue